Tredaptive: Cholesterol Drug Fails In Trial
Merck said it no longer planned to seek regulatory approval for the drug in the United States and is advising doctors in
tredaptive cholesterol drug fail trial merck say long plan seek regulatory approval drug united states advise doctor